Visualizing Vascular Mechanisms of Salt Sensitivity

August 28, 2023 updated by: Rachelle Crescenzi, Vanderbilt University Medical Center
This study aims to assess the salt sensitive blood pressure response to dietary salt load compared with radiological markers of salt handling.

Study Overview

Detailed Description

Hypertension is a major cause of heart disease, heart failure, and stroke. Hypertension, or high blood pressure, affects people differently and is related to the body's ability to maintain healthy circulation of salt. Some individuals may be affected by salt sensitive blood pressure (SSBP), when their blood pressure changes in response to dietary salt load. SSBP is a prevalent, independent risk factor for developing cardiovascular disease that preferentially affects black individuals. Current methods to assess SSBP require dietary salt loading over the course of days to weeks, and measurement of blood pressure following high salt diet and low salt diet. Such lengthy protocols are not feasible in a clinical setting to evaluate this risk factor for cardiovascular disease, and more importantly, these procedures provide incomplete information about mechanisms of salt sensitivity.

Our knowledge regarding salt handling in the body is limited. While renal dysfunction is partly responsible for SSBP, recent research points to the role of lymphatic vascular clearance in regulating tissue salt storage and blood pressure control. To better understand these mechanisms in vivo, we have recently developed a noninvasive magnetic resonance (MR) lymphangiography method sensitive to lymphatic vasculature, and applied standardized MR protocols for measuring tissue sodium and fat storage in adults with impaired lymphatic clearance. We found evidence of lymph stasis and tissue salt deposition that correlated with local subcutaneous fat volume. Here, we will test whether similar lymphatic pathways are impaired in persons with SSBP, leading to tissue salt and fat storage, in comparison to the involvement of renal dysfunction in SSBP tissue profiles.

The aims of this study are to improve our understanding of vascular mechanisms of human salt storage, and to provide standardized radiologic biomarkers sensitive to the SSBP phenotype. This study will test the primary hypothesis that the SSBP response is correlated with baseline tissue sodium storage, and elevated in persons with salt sensitivity. Secondary hypotheses will address whether the SSBP response is related to fat storage, lymphatic vascular function, renal vascular function, and impaired target organ responses to salt loading, including decreased urinary sodium excretion, and less suppression of plasma renin and serum aldosterone.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37212
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Identification as black race
  • Age between 18 and 55 years
  • Body mass index between 25 and <35 kg/m2
  • Normotensive or pre-hypertensive
  • Willing to adhere to study diets
  • Able to provide informed consent and communicate with study personnel

Exclusion Criteria:

  • Prevalent cardiovascular disease or use of medications for cardiovascular disease
  • Current or prior history of hypertension or use of blood pressure lowering medications
  • Current or prior history of diabetes mellitus or use of anti-diabetic medications
  • Prevalent renal disease (eGFR < 60 ml/min/1.73m2), abnormal serum sodium or potassium
  • Current or prior smoker
  • Current pregnancy, or use of hormone replacement therapy or oral contraceptive
  • Current steroid use
  • Contraindications to MRI
  • Active infection or open wounds on the top of the feet or hands

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low- then high-salt diet
10 subjects will be enrolled and each will undergo study procedures at 4 separate visits. Subjects will be randomly assigned to this study arm, differing in the order of low and high salt diets. After a baseline visit to include a noninvasive MRI scan, the subject will begin this study diet: low-salt diet, then washout consisting of the subject's typical diet, then high-salt diet. Each dietary or washout period lasts for 7 days, and study visits will occur after each period.
The low-salt diet (7 days) will consist of meals, snacks and water provided by Vanderbilt's metabolic kitchen.
The high-salt diet (7 days) consists of each subject's typical diet, supplemented each day with 2 bullion broth packets, which will be provided to the subject by the study staff.
Experimental: High- then low-salt diet
10 subjects will be enrolled and each will undergo study procedures at 4 separate visits. Subjects will be randomly assigned to this study arm, differing in the order of low and high salt diets. After a baseline visit to include a noninvasive MRI scan, the subject will begin this study diet: high-salt diet, then washout consisting of the subject's typical diet, then low-salt diet. Each dietary or washout period lasts for 7 days, and study visits will occur after each period.
The low-salt diet (7 days) will consist of meals, snacks and water provided by Vanderbilt's metabolic kitchen.
The high-salt diet (7 days) consists of each subject's typical diet, supplemented each day with 2 bullion broth packets, which will be provided to the subject by the study staff.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Salt-sensitive blood pressure after low salt diet
Time Frame: Following completion of all dietary supplements and washout, in no less than 21 days.
Measured as the difference in mean arterial pressure following high-salt diet compared to low-salt diet
Following completion of all dietary supplements and washout, in no less than 21 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tissue sodium content of the legs
Time Frame: At baseline
Measured by sodium MRI
At baseline
Fat fraction of the legs
Time Frame: At baseline
Measured by conventional MRI, in units of fat/water volume ratio
At baseline
Kidney blood perfusion rate
Time Frame: At baseline
Measured by conventional noninvasive MRI
At baseline
Lymphatic stasis of the legs
Time Frame: At baseline
Measured by noninvasive MR lymphangiography
At baseline
Urinary sodium excretion
Time Frame: At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.
Measured from 24-hour urine collection
At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.
Plasma renin
Time Frame: At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.
Physiological parameter
At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.
Serum aldosterone
Time Frame: At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.
Physiological parameter
At baseline and each of 3 study visits occurring about every 7 days, to be completed in no less than 21 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rachelle Crescenzi, PhD, Department of Radiology, Vanderbilt University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

November 4, 2022

Study Completion (Actual)

November 4, 2022

Study Registration Dates

First Submitted

September 25, 2018

First Submitted That Met QC Criteria

October 3, 2018

First Posted (Actual)

October 4, 2018

Study Record Updates

Last Update Posted (Actual)

August 29, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Low-salt diet

3
Subscribe